Loading…
Immune response and possible therapeutics in COVID-19
COVID-19 has emerged as a pandemic affecting about 213 countries in all the continents of the globe, resulting in more than 37.8 million individuals getting infected and over 1.08 million deaths worldwide, jeopardizing global human health and the economy. This presents an urgent need to develop ther...
Saved in:
| Published in: | RSC advances 2021-01, Vol.11 (2), p.96-977 |
|---|---|
| Main Authors: | , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c428t-ecc36a2273713619b88893bcbc5552733e60e95d82f118e5549b38e8448aceed3 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c428t-ecc36a2273713619b88893bcbc5552733e60e95d82f118e5549b38e8448aceed3 |
| container_end_page | 977 |
| container_issue | 2 |
| container_start_page | 96 |
| container_title | RSC advances |
| container_volume | 11 |
| creator | Dutta, Anindya Roy, Ananya Roy, Laboni Chattopadhyay, Samit Chatterjee, Subhrangsu |
| description | COVID-19 has emerged as a pandemic affecting about 213 countries in all the continents of the globe, resulting in more than 37.8 million individuals getting infected and over 1.08 million deaths worldwide, jeopardizing global human health and the economy. This presents an urgent need to develop therapies that target the SARS-CoV2 virus specifically. This review aims at presenting the available information on the coronavirus disease 2019 along with various drugs that are having widespread use until a vaccine candidate is available to aid in the development of therapeutic strategies against COVID-19.
While the world stands a witness to the havoc of COVID-19, we must continue our quest of exploring various small molecule drugs and biologics as therapeutic strategies to fight the pandemic. |
| doi_str_mv | 10.1039/d0ra08901j |
| format | article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2651691363</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2476615514</sourcerecordid><originalsourceid>FETCH-LOGICAL-c428t-ecc36a2273713619b88893bcbc5552733e60e95d82f118e5549b38e8448aceed3</originalsourceid><addsrcrecordid>eNpdkUtLAzEUhYMoVrQb98qAGxFG826yEaS-KoIg6jZkMrd2yrxMZgT_vanVWs0mIffj5OQchPYJPiWY6bMce4uVxmS-gXYo5jKlWOrNtfMADUOY47ikIFSSbTRgglM2ImwHiUlV9TUkHkLb1AESW-dJ24RQZCUk3Qy8baHvCheSok7GDy-Ty5ToPbQ1tWWA4fe-i56vr57Gt-n9w81kfHGfOk5Vl4JzTFpKR4u3JNGZUkqzzGVOCBFvGUgMWuSKTglRIATXGVOgOFfWAeRsF50vdds-qyB3UHfelqb1RWX9h2lsYf5O6mJmXpt3o6RmnPIocPwt4Ju3HkJnqiI4KEtbQ9MHQ2MkUkdzLKJH_9B50_s6fs9QPpKSCEEWgidLyvkYkofpygzBZlGIucSPF1-F3EX4cN3-Cv2JPwIHS8AHt5r-Nso-AfB1jYQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2476615514</pqid></control><display><type>article</type><title>Immune response and possible therapeutics in COVID-19</title><source>PubMed Central</source><creator>Dutta, Anindya ; Roy, Ananya ; Roy, Laboni ; Chattopadhyay, Samit ; Chatterjee, Subhrangsu</creator><creatorcontrib>Dutta, Anindya ; Roy, Ananya ; Roy, Laboni ; Chattopadhyay, Samit ; Chatterjee, Subhrangsu</creatorcontrib><description>COVID-19 has emerged as a pandemic affecting about 213 countries in all the continents of the globe, resulting in more than 37.8 million individuals getting infected and over 1.08 million deaths worldwide, jeopardizing global human health and the economy. This presents an urgent need to develop therapies that target the SARS-CoV2 virus specifically. This review aims at presenting the available information on the coronavirus disease 2019 along with various drugs that are having widespread use until a vaccine candidate is available to aid in the development of therapeutic strategies against COVID-19.
While the world stands a witness to the havoc of COVID-19, we must continue our quest of exploring various small molecule drugs and biologics as therapeutic strategies to fight the pandemic.</description><identifier>ISSN: 2046-2069</identifier><identifier>EISSN: 2046-2069</identifier><identifier>DOI: 10.1039/d0ra08901j</identifier><identifier>PMID: 35423713</identifier><language>eng</language><publisher>England: Royal Society of Chemistry</publisher><subject>Chemistry ; Coronaviruses ; COVID-19 ; Viral diseases</subject><ispartof>RSC advances, 2021-01, Vol.11 (2), p.96-977</ispartof><rights>This journal is © The Royal Society of Chemistry.</rights><rights>Copyright Royal Society of Chemistry 2021</rights><rights>This journal is © The Royal Society of Chemistry 2021 The Royal Society of Chemistry</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c428t-ecc36a2273713619b88893bcbc5552733e60e95d82f118e5549b38e8448aceed3</citedby><cites>FETCH-LOGICAL-c428t-ecc36a2273713619b88893bcbc5552733e60e95d82f118e5549b38e8448aceed3</cites><orcidid>0000-0002-3250-7311</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693424/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693424/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35423713$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dutta, Anindya</creatorcontrib><creatorcontrib>Roy, Ananya</creatorcontrib><creatorcontrib>Roy, Laboni</creatorcontrib><creatorcontrib>Chattopadhyay, Samit</creatorcontrib><creatorcontrib>Chatterjee, Subhrangsu</creatorcontrib><title>Immune response and possible therapeutics in COVID-19</title><title>RSC advances</title><addtitle>RSC Adv</addtitle><description>COVID-19 has emerged as a pandemic affecting about 213 countries in all the continents of the globe, resulting in more than 37.8 million individuals getting infected and over 1.08 million deaths worldwide, jeopardizing global human health and the economy. This presents an urgent need to develop therapies that target the SARS-CoV2 virus specifically. This review aims at presenting the available information on the coronavirus disease 2019 along with various drugs that are having widespread use until a vaccine candidate is available to aid in the development of therapeutic strategies against COVID-19.
While the world stands a witness to the havoc of COVID-19, we must continue our quest of exploring various small molecule drugs and biologics as therapeutic strategies to fight the pandemic.</description><subject>Chemistry</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>Viral diseases</subject><issn>2046-2069</issn><issn>2046-2069</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNpdkUtLAzEUhYMoVrQb98qAGxFG826yEaS-KoIg6jZkMrd2yrxMZgT_vanVWs0mIffj5OQchPYJPiWY6bMce4uVxmS-gXYo5jKlWOrNtfMADUOY47ikIFSSbTRgglM2ImwHiUlV9TUkHkLb1AESW-dJ24RQZCUk3Qy8baHvCheSok7GDy-Ty5ToPbQ1tWWA4fe-i56vr57Gt-n9w81kfHGfOk5Vl4JzTFpKR4u3JNGZUkqzzGVOCBFvGUgMWuSKTglRIATXGVOgOFfWAeRsF50vdds-qyB3UHfelqb1RWX9h2lsYf5O6mJmXpt3o6RmnPIocPwt4Ju3HkJnqiI4KEtbQ9MHQ2MkUkdzLKJH_9B50_s6fs9QPpKSCEEWgidLyvkYkofpygzBZlGIucSPF1-F3EX4cN3-Cv2JPwIHS8AHt5r-Nso-AfB1jYQ</recordid><startdate>20210104</startdate><enddate>20210104</enddate><creator>Dutta, Anindya</creator><creator>Roy, Ananya</creator><creator>Roy, Laboni</creator><creator>Chattopadhyay, Samit</creator><creator>Chatterjee, Subhrangsu</creator><general>Royal Society of Chemistry</general><general>The Royal Society of Chemistry</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7SR</scope><scope>8BQ</scope><scope>8FD</scope><scope>JG9</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-3250-7311</orcidid></search><sort><creationdate>20210104</creationdate><title>Immune response and possible therapeutics in COVID-19</title><author>Dutta, Anindya ; Roy, Ananya ; Roy, Laboni ; Chattopadhyay, Samit ; Chatterjee, Subhrangsu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c428t-ecc36a2273713619b88893bcbc5552733e60e95d82f118e5549b38e8448aceed3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Chemistry</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>Viral diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dutta, Anindya</creatorcontrib><creatorcontrib>Roy, Ananya</creatorcontrib><creatorcontrib>Roy, Laboni</creatorcontrib><creatorcontrib>Chattopadhyay, Samit</creatorcontrib><creatorcontrib>Chatterjee, Subhrangsu</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Engineered Materials Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>Materials Research Database</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>RSC advances</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dutta, Anindya</au><au>Roy, Ananya</au><au>Roy, Laboni</au><au>Chattopadhyay, Samit</au><au>Chatterjee, Subhrangsu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immune response and possible therapeutics in COVID-19</atitle><jtitle>RSC advances</jtitle><addtitle>RSC Adv</addtitle><date>2021-01-04</date><risdate>2021</risdate><volume>11</volume><issue>2</issue><spage>96</spage><epage>977</epage><pages>96-977</pages><issn>2046-2069</issn><eissn>2046-2069</eissn><abstract>COVID-19 has emerged as a pandemic affecting about 213 countries in all the continents of the globe, resulting in more than 37.8 million individuals getting infected and over 1.08 million deaths worldwide, jeopardizing global human health and the economy. This presents an urgent need to develop therapies that target the SARS-CoV2 virus specifically. This review aims at presenting the available information on the coronavirus disease 2019 along with various drugs that are having widespread use until a vaccine candidate is available to aid in the development of therapeutic strategies against COVID-19.
While the world stands a witness to the havoc of COVID-19, we must continue our quest of exploring various small molecule drugs and biologics as therapeutic strategies to fight the pandemic.</abstract><cop>England</cop><pub>Royal Society of Chemistry</pub><pmid>35423713</pmid><doi>10.1039/d0ra08901j</doi><tpages>18</tpages><orcidid>https://orcid.org/0000-0002-3250-7311</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2046-2069 |
| ispartof | RSC advances, 2021-01, Vol.11 (2), p.96-977 |
| issn | 2046-2069 2046-2069 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2651691363 |
| source | PubMed Central |
| subjects | Chemistry Coronaviruses COVID-19 Viral diseases |
| title | Immune response and possible therapeutics in COVID-19 |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-24T03%3A38%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immune%20response%20and%20possible%20therapeutics%20in%20COVID-19&rft.jtitle=RSC%20advances&rft.au=Dutta,%20Anindya&rft.date=2021-01-04&rft.volume=11&rft.issue=2&rft.spage=96&rft.epage=977&rft.pages=96-977&rft.issn=2046-2069&rft.eissn=2046-2069&rft_id=info:doi/10.1039/d0ra08901j&rft_dat=%3Cproquest_pubme%3E2476615514%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c428t-ecc36a2273713619b88893bcbc5552733e60e95d82f118e5549b38e8448aceed3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2476615514&rft_id=info:pmid/35423713&rfr_iscdi=true |